NEW BRUNSWICK, N.J.,
April 1, 2020 /PRNewswire/
-- Johnson & Johnson (NYSE: JNJ) today announced that, in
light of the evolving situation with the coronavirus outbreak
(COVID-19), it will reschedule its 2020 Medical Devices Business
Review that was planned to take place on May
13, 2020. Johnson & Johnson will continue to
monitor the situation closely and follow guidance from health
authorities to determine a future date.
The decision was made to protect the health and safety of
employees, partners and attendees, while also supporting the wider
public effort to slow the spread of the virus as the global
COVID-19 pandemic continues to develop.
As a leader in global health, Johnson & Johnson's top
priority remains our patients, customers and employees. We are
partnering with global and local health authorities to address
immediate and long-term health care needs, to ensure sustainable
supply of our critical medicines, as well as to research potential
vaccines and therapeutics. We will remain on the front lines of
this health crisis, bringing our full resources and minds to combat
it.
About Johnson & Johnson
At Johnson & Johnson,
we believe good health is the foundation of vibrant lives, thriving
communities and forward progress. That's why for more than 133
years, we have aimed to keep people well at every age and every
stage of life. Today, as the world's largest and most broadly-based
health care company, we are committed to using our reach and size
for good. We strive to improve access and affordability, create
healthier communities, and put a healthy mind, body and environment
within reach of everyone, everywhere. We are blending our heart,
science and ingenuity to profoundly change the trajectory of health
for humanity.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-postpones-2020-medical-devices-business-review-due-to-the-coronavirus-301033657.html
SOURCE Johnson & Johnson